Use of isothiocyanate structural modified compound for preventing or treating liver disease

Provided is a use of an isothiocyanate structural modified compound in the manufacture of the pharmaceutical composition for preventing or treating a liver disease in a subject, and the pharmaceutical composition includes the isothiocyanate structural modified compound and a pharmaceutically accepta...

Full description

Saved in:
Bibliographic Details
Main Authors HWANG, CHAN-KOU, LIN, KOUNG, WU, JAWING, CHANG, YUNG-SHENG, KAO, KUO-HSI
Format Patent
LanguageChinese
English
Published 16.04.2024
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:Provided is a use of an isothiocyanate structural modified compound in the manufacture of the pharmaceutical composition for preventing or treating a liver disease in a subject, and the pharmaceutical composition includes the isothiocyanate structural modified compound and a pharmaceutically acceptable carrier thereof.
Bibliography:Application Number: TW202211139101